10x Genomics xenium Prime 5K Reagents (Ambis 2261543) Tender, USA - 119247961

Procurement Summary

Country : USA

Summary : 10x Genomics xenium Prime 5K Reagents (Ambis 2261543)

Deadline : 22 May 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 119247961

Document Ref. No. : RFQ-NIAID-25-2261543

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items, ” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2261543 and the solicitation is issued as a Request for Quotes (RFQ).



This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-3 January 17, 2025.



The North American Industry Classification System (NAICS) code for this procurement is 325414, Biological Product (except Diagnostic) Manufacturing, with a size standard of 1, 250 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.



Project Description:

The NIH, NIAID, LISB, has a current requirement for 10x Genomics reagents. The LISB investigates basic aspects of innate and adaptive immune function and how the body responses to viral infections. Using new technologies, LISB aims to understand the complex dynamics of the virus-host interactions to be able to perturb the system and produce a positive outcome. The LISB is divided up into multiple labs with varying specialties. The Schwartzberg Lab applies xenium Prime 5K kit technologies to improve our understanding of how tissue resident lymphocyte contribute to the prevention or the establishment of autoimmune manifestations in exocrine, endocrine and mucosal tissues in mouse models of primary immunodeficiencies. This type of knowledge is expected ...
Active Contract Opportunity
Notice ID : RFQ-NIAID-25-2261543
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: May 15, 2025 01:14 pm EDT
Original Date Offers Due: May 22, 2025 10:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Jun 06, 2025
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Bethesda, MD 20892 USA

Documents

 Tender Notice

RFQ-NIAID-25-2261543_FAR_52.pdf